Evidence map›Paper›PMID 33083396›Full record

ArticleWorld journal of clinical cases2020

Prolonged prothrombin time at admission predicts poor clinical outcome in COVID-19 patients.

Lang Wang, Wen-Bo He, Xiao-Mei Yu, Da-Long Hu, Hong Jiang

Open access · diamondAbstract read
In one paragraph

Article in World journal of clinical cases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Lang WangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China.
Wen-Bo HeDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China.
Xiao-Mei YuDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China.
Da-Long HuSchool of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney 2052, Australia.
Hong JiangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China.
Wuhan University · CNRenmin Hospital of Wuhan University · CNUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prognostic value of coagulation disorder in coronavirus disease 2019 (COVID-19) patients should be demonstrated.

aimTo investigate the abnormalities of coagulation parameters in the patients with COVID-19 and their prognostic values.

methodsConsecutive patients admitted in the isolation ward of Renmin Hospital of Wuhan University from January 31 to February 5, 2020 with confirmed COVID-19 were included. The primary outcomes were death and survival as of March 11. Demographics, vital signs, comorbidities and laboratory tests were collected and compared between those who died and survivors. Logistic regression analysis for prognostic factors was performed. Kaplan-Meier analysis was used to compare the estimated survival rate between patients with prolonged prothrombin time and normal prothrombin time.

resultsThe total number of patients with confirmed COVID-19 who were enrolled was 213. The median age was 62 years, and 95 patients (44.6%) were men. Fifty-one patients were critical (23.9%), 79 patients were severe (37.1%) and 83 patients were moderate (39%). As of March 11, 2020, 99 patients were discharged (46.5%), 79 patients (37.1%) stayed in the hospital and 35 patients (16.2%) died. Median time to death was 6 (4-8) d, while median hospital stay was 32 (22-36) d in survivors (

conclusionProthrombin time, concentration of fibrin degradation products, respiration rate and age were predictive factors for clinical outcomes of COVID-19 patients.

Indexed as

CoagulationCOVID-19Fibrin degradation productsInfectious diseasePrognosisProthrombin time

Identifiers

PMID33083396
PMCPMC7559677
OpenAlexW3089265875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.